Antiviral Oral Liquid Market, Global Outlook and Forecast 2022-2028

January 2022 | 110 pages | ID: ABED01837736EN
Market Monitor Global

Abstracts

Antiviral Oral liquids are homogeneous liquid preparations, usually contains a solution, an emulsion or a suspension of one or more active ingredients in a suitable liquid base.

This report contains market size and forecasts of Antiviral Oral Liquid in Global, including the following market information:

Global Antiviral Oral Liquid Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antiviral Oral Liquid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Syrup Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiviral Oral Liquid include Pfizer, Roche, Novartis, Merck, GlaxoSmithKline, Johnson & Johnson, AbbVie, Sanofi and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiviral Oral Liquid companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiviral Oral Liquid Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antiviral Oral Liquid Market Segment Percentages, by Type, 2021 (%)

• Syrup
• Oral suspension
• Oral solution
• Oral drop
• Oral emulsion
• Mixture

Global Antiviral Oral Liquid Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antiviral Oral Liquid Market Segment Percentages, by Application, 2021 (%)

• Adults
• Children

Global Antiviral Oral Liquid Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antiviral Oral Liquid Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiviral Oral Liquid revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antiviral Oral Liquid revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Roche
• Novartis
• Merck
• GlaxoSmithKline
• Johnson & Johnson
• AbbVie
• Sanofi
• Bristol-Myers Squibb
• AstraZeneca
• Eli Lilly
• Novo Nordisk
• Amgen
• Gilead Sciences
• CSL
• Takeda Pharmaceuticals
• Bayer
• Celgene
• Merck KGaA
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiviral Oral Liquid Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiviral Oral Liquid Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIVIRAL ORAL LIQUID OVERALL MARKET SIZE

2.1 Global Antiviral Oral Liquid Market Size: 2021 VS 2028
2.2 Global Antiviral Oral Liquid Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antiviral Oral Liquid Players in Global Market
3.2 Top Global Antiviral Oral Liquid Companies Ranked by Revenue
3.3 Global Antiviral Oral Liquid Revenue by Companies
3.4 Top 3 and Top 5 Antiviral Oral Liquid Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antiviral Oral Liquid Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiviral Oral Liquid Players in Global Market
  3.6.1 List of Global Tier 1 Antiviral Oral Liquid Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antiviral Oral Liquid Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antiviral Oral Liquid Market Size Markets, 2021 & 2028
  4.1.2 Syrup
  4.1.3 Oral suspension
  4.1.4 Oral solution
  4.1.5 Oral drop
  4.1.6 Oral emulsion
  4.1.7 Mixture
4.2 By Type - Global Antiviral Oral Liquid Revenue & Forecasts
  4.2.1 By Type - Global Antiviral Oral Liquid Revenue, 2017-2022
  4.2.2 By Type - Global Antiviral Oral Liquid Revenue, 2023-2028
  4.2.3 By Type - Global Antiviral Oral Liquid Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiviral Oral Liquid Market Size, 2021 & 2028
  5.1.2 Adults
  5.1.3 Children
5.2 By Application - Global Antiviral Oral Liquid Revenue & Forecasts
  5.2.1 By Application - Global Antiviral Oral Liquid Revenue, 2017-2022
  5.2.2 By Application - Global Antiviral Oral Liquid Revenue, 2023-2028
  5.2.3 By Application - Global Antiviral Oral Liquid Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiviral Oral Liquid Market Size, 2021 & 2028
6.2 By Region - Global Antiviral Oral Liquid Revenue & Forecasts
  6.2.1 By Region - Global Antiviral Oral Liquid Revenue, 2017-2022
  6.2.2 By Region - Global Antiviral Oral Liquid Revenue, 2023-2028
  6.2.3 By Region - Global Antiviral Oral Liquid Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antiviral Oral Liquid Revenue, 2017-2028
  6.3.2 US Antiviral Oral Liquid Market Size, 2017-2028
  6.3.3 Canada Antiviral Oral Liquid Market Size, 2017-2028
  6.3.4 Mexico Antiviral Oral Liquid Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antiviral Oral Liquid Revenue, 2017-2028
  6.4.2 Germany Antiviral Oral Liquid Market Size, 2017-2028
  6.4.3 France Antiviral Oral Liquid Market Size, 2017-2028
  6.4.4 U.K. Antiviral Oral Liquid Market Size, 2017-2028
  6.4.5 Italy Antiviral Oral Liquid Market Size, 2017-2028
  6.4.6 Russia Antiviral Oral Liquid Market Size, 2017-2028
  6.4.7 Nordic Countries Antiviral Oral Liquid Market Size, 2017-2028
  6.4.8 Benelux Antiviral Oral Liquid Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antiviral Oral Liquid Revenue, 2017-2028
  6.5.2 China Antiviral Oral Liquid Market Size, 2017-2028
  6.5.3 Japan Antiviral Oral Liquid Market Size, 2017-2028
  6.5.4 South Korea Antiviral Oral Liquid Market Size, 2017-2028
  6.5.5 Southeast Asia Antiviral Oral Liquid Market Size, 2017-2028
  6.5.6 India Antiviral Oral Liquid Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antiviral Oral Liquid Revenue, 2017-2028
  6.6.2 Brazil Antiviral Oral Liquid Market Size, 2017-2028
  6.6.3 Argentina Antiviral Oral Liquid Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antiviral Oral Liquid Revenue, 2017-2028
  6.7.2 Turkey Antiviral Oral Liquid Market Size, 2017-2028
  6.7.3 Israel Antiviral Oral Liquid Market Size, 2017-2028
  6.7.4 Saudi Arabia Antiviral Oral Liquid Market Size, 2017-2028
  6.7.5 UAE Antiviral Oral Liquid Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Antiviral Oral Liquid Major Product Offerings
  7.1.4 Pfizer Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Antiviral Oral Liquid Major Product Offerings
  7.2.4 Roche Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Antiviral Oral Liquid Major Product Offerings
  7.3.4 Novartis Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Antiviral Oral Liquid Major Product Offerings
  7.4.4 Merck Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Antiviral Oral Liquid Major Product Offerings
  7.5.4 GlaxoSmithKline Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Antiviral Oral Liquid Major Product Offerings
  7.6.4 Johnson & Johnson Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 AbbVie
  7.7.1 AbbVie Corporate Summary
  7.7.2 AbbVie Business Overview
  7.7.3 AbbVie Antiviral Oral Liquid Major Product Offerings
  7.7.4 AbbVie Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.7.5 AbbVie Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Antiviral Oral Liquid Major Product Offerings
  7.8.4 Sanofi Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Major Product Offerings
  7.9.4 Bristol-Myers Squibb Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 AstraZeneca
  7.10.1 AstraZeneca Corporate Summary
  7.10.2 AstraZeneca Business Overview
  7.10.3 AstraZeneca Antiviral Oral Liquid Major Product Offerings
  7.10.4 AstraZeneca Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.10.5 AstraZeneca Key News
7.11 Eli Lilly
  7.11.1 Eli Lilly Corporate Summary
  7.11.2 Eli Lilly Business Overview
  7.11.3 Eli Lilly Antiviral Oral Liquid Major Product Offerings
  7.11.4 Eli Lilly Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.11.5 Eli Lilly Key News
7.12 Novo Nordisk
  7.12.1 Novo Nordisk Corporate Summary
  7.12.2 Novo Nordisk Business Overview
  7.12.3 Novo Nordisk Antiviral Oral Liquid Major Product Offerings
  7.12.4 Novo Nordisk Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.12.5 Novo Nordisk Key News
7.13 Amgen
  7.13.1 Amgen Corporate Summary
  7.13.2 Amgen Business Overview
  7.13.3 Amgen Antiviral Oral Liquid Major Product Offerings
  7.13.4 Amgen Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.13.5 Amgen Key News
7.14 Gilead Sciences
  7.14.1 Gilead Sciences Corporate Summary
  7.14.2 Gilead Sciences Business Overview
  7.14.3 Gilead Sciences Antiviral Oral Liquid Major Product Offerings
  7.14.4 Gilead Sciences Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.14.5 Gilead Sciences Key News
7.15 CSL
  7.15.1 CSL Corporate Summary
  7.15.2 CSL Business Overview
  7.15.3 CSL Antiviral Oral Liquid Major Product Offerings
  7.15.4 CSL Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.15.5 CSL Key News
7.16 Takeda Pharmaceuticals
  7.16.1 Takeda Pharmaceuticals Corporate Summary
  7.16.2 Takeda Pharmaceuticals Business Overview
  7.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Major Product Offerings
  7.16.4 Takeda Pharmaceuticals Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.16.5 Takeda Pharmaceuticals Key News
7.17 Bayer
  7.17.1 Bayer Corporate Summary
  7.17.2 Bayer Business Overview
  7.17.3 Bayer Antiviral Oral Liquid Major Product Offerings
  7.17.4 Bayer Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.17.5 Bayer Key News
7.18 Celgene
  7.18.1 Celgene Corporate Summary
  7.18.2 Celgene Business Overview
  7.18.3 Celgene Antiviral Oral Liquid Major Product Offerings
  7.18.4 Celgene Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.18.5 Celgene Key News
7.19 Merck KGaA
  7.19.1 Merck KGaA Corporate Summary
  7.19.2 Merck KGaA Business Overview
  7.19.3 Merck KGaA Antiviral Oral Liquid Major Product Offerings
  7.19.4 Merck KGaA Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.19.5 Merck KGaA Key News
7.20 Allergan
  7.20.1 Allergan Corporate Summary
  7.20.2 Allergan Business Overview
  7.20.3 Allergan Antiviral Oral Liquid Major Product Offerings
  7.20.4 Allergan Antiviral Oral Liquid Revenue in Global Market (2017-2022)
  7.20.5 Allergan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antiviral Oral Liquid Market Opportunities & Trends in Global Market
Table 2. Antiviral Oral Liquid Market Drivers in Global Market
Table 3. Antiviral Oral Liquid Market Restraints in Global Market
Table 4. Key Players of Antiviral Oral Liquid in Global Market
Table 5. Top Antiviral Oral Liquid Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antiviral Oral Liquid Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antiviral Oral Liquid Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antiviral Oral Liquid Product Type
Table 9. List of Global Tier 1 Antiviral Oral Liquid Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Oral Liquid Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiviral Oral Liquid Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antiviral Oral Liquid Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antiviral Oral Liquid Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antiviral Oral Liquid Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antiviral Oral Liquid Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antiviral Oral Liquid Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antiviral Oral Liquid Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antiviral Oral Liquid Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antiviral Oral Liquid Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antiviral Oral Liquid Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Antiviral Oral Liquid Product Offerings
Table 32. Pfizer Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Antiviral Oral Liquid Product Offerings
Table 35. Roche Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Antiviral Oral Liquid Product Offerings
Table 38. Novartis Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Antiviral Oral Liquid Product Offerings
Table 41. Merck Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Antiviral Oral Liquid Product Offerings
Table 44. GlaxoSmithKline Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Antiviral Oral Liquid Product Offerings
Table 47. Johnson & Johnson Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Corporate Summary
Table 49. AbbVie Antiviral Oral Liquid Product Offerings
Table 50. AbbVie Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Antiviral Oral Liquid Product Offerings
Table 53. Sanofi Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Antiviral Oral Liquid Product Offerings
Table 56. Bristol-Myers Squibb Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 57. AstraZeneca Corporate Summary
Table 58. AstraZeneca Antiviral Oral Liquid Product Offerings
Table 59. AstraZeneca Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 60. Eli Lilly Corporate Summary
Table 61. Eli Lilly Antiviral Oral Liquid Product Offerings
Table 62. Eli Lilly Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 63. Novo Nordisk Corporate Summary
Table 64. Novo Nordisk Antiviral Oral Liquid Product Offerings
Table 65. Novo Nordisk Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 66. Amgen Corporate Summary
Table 67. Amgen Antiviral Oral Liquid Product Offerings
Table 68. Amgen Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 69. Gilead Sciences Corporate Summary
Table 70. Gilead Sciences Antiviral Oral Liquid Product Offerings
Table 71. Gilead Sciences Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 72. CSL Corporate Summary
Table 73. CSL Antiviral Oral Liquid Product Offerings
Table 74. CSL Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 75. Takeda Pharmaceuticals Corporate Summary
Table 76. Takeda Pharmaceuticals Antiviral Oral Liquid Product Offerings
Table 77. Takeda Pharmaceuticals Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 78. Bayer Corporate Summary
Table 79. Bayer Antiviral Oral Liquid Product Offerings
Table 80. Bayer Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 81. Celgene Corporate Summary
Table 82. Celgene Antiviral Oral Liquid Product Offerings
Table 83. Celgene Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 84. Merck KGaA Corporate Summary
Table 85. Merck KGaA Antiviral Oral Liquid Product Offerings
Table 86. Merck KGaA Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)
Table 87. Allergan Corporate Summary
Table 88. Allergan Antiviral Oral Liquid Product Offerings
Table 89. Allergan Antiviral Oral Liquid Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antiviral Oral Liquid Segment by Type in 2021
Figure 2. Antiviral Oral Liquid Segment by Application in 2021
Figure 3. Global Antiviral Oral Liquid Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiviral Oral Liquid Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiviral Oral Liquid Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2021
Figure 8. By Type - Global Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 12. US Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 16. Germany Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 17. France Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 24. China Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 28. India Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 30. Brazil Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antiviral Oral Liquid Revenue Market Share, 2017-2028
Figure 33. Turkey Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antiviral Oral Liquid Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AstraZeneca Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Eli Lilly Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novo Nordisk Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Amgen Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Gilead Sciences Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. CSL Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Takeda Pharmaceuticals Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Bayer Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Celgene Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Merck KGaA Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Allergan Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2017-2022)